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BK virus (BKV) is a member of the polyoma virus family that is ubiquitous in humans. Its 5-kb DNA genome consists of a
bidirectional promoter region situated between two temporally regulated coding regions. We mapped the transcription
initiation site of the major late promoter (MLP) of the archetype strain BKV(WW) to nt 185. We found that it lies within the
sequence TGGN6GCCA, a binding site for members of the nuclear factor 1 (NF1) family of transcription factors. Competition
electrophoretic mobility shift and immunoshift assays confirmed that NF1 factors present in nuclear extracts of HeLa and
CV-1 cells bind to the BKV-MLP. Because BKV(WW) grew poorly in tissue culture and failed to express detectable levels of
RNA in vitro, SV40-BKV chimeric viruses were constructed to investigate the transcriptional function of this NF-1 binding site.
These sequence-specific factors repressed transcription in a cell-free system when template copy number was low. This
repression could be relieved by the addition in trans of oligonucleotides containing wild-type, but not mutated, NF1-binding
site sequences. SV40-BKV chimeric viruses defective in this NF1-binding site overproduced late RNA at early, but not late,
times after transfection of CV-1 cells. Finally, transient expression in 293 cells of cDNAs encoding the family members
NF1-A4, NF1-C2, and NF1-X2 specifically repressed transcription from the BKV late promoter approximately 3-, 10-, and
10-fold, respectively, in a DNA binding-dependent manner. We conclude that some members of the NF1 family of transcription
factors can act as sequence-specific cellular repressors of the BKV-MLP. We propose that titration of these and other cellular
repressors by viral genome amplification may be responsible in part for the replication-dependent component of the
early-to-late switch in BKV gene expression. © 2001 Academic PressINTRODUCTION
BK virus (BKV) is a member of the polyoma virus family
of oncogenic DNA viruses (Gardner et al., 1971; Sief et
al., 1979; Howley, 1980; Small et al., 1986). Approximately
0% of humans have been infected with BKV by adult-
ood (Schreier and Gruber, 1986). The virus primarily
nfects the kidney, where it persists in a largely latent and
ndetectable state. However, immunosuppression of the
ost by pregnancy, disease, or treatment with certain
rugs frequently leads to active replication of the virus
Schreier and Gruber, 1986).
Several different strains of BKV have been isolated and
equenced. All of them show extensive sequence homol-
gy in their two protein-coding regions, but considerable
eterogeneity in their bidirectional promoter regions (Ru-
instein et al., 1989; Rubinstein, 1991; Negrini et al.,
1991). Whether these strains exist in nature or are an
artifact of passage in cells in culture remains unclear
(Rubinstein and Harley, 1989). One strain, BKV(WW), iso-
lated and cloned directly from human urine, is consid-
ered to be the archetype strain (Chauhan et al., 1984;
Rubinstein et al., 1987; Rubinstein and Harley, 1989; Ne-
grini et al., 1991).
As with simian virus 40 (SV40), a monkey homolog of
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 608-262-2824. E-mail: mertz@oncology.wisc.edu.89BKV, the early region of BKVs 5-kb genome is expressed
early in the lytic cycle of infection. It encodes the large (T)
and small tumor (t) antigens. Large T antigen autoregu-
lates early gene transcription (Deyerle et al., 1989) and
plays multiple roles in viral DNA replication and trans-
activation of late gene expression (Cassill and Subra-
mani, 1988; Cassill et al., 1989). The late genes encode
the virion proteins, VP1, VP2, and VP3, and a leader-
encoded protein called agnoprotein. The late region is
expressed at significant levels only after the onset of
viral DNA replication.
Our laboratory has been studying the mechanisms by
which the SV40 genes are temporally regulated. We have
identified hormone response elements within the proxi-
mal region of the major late promoter of SV40 that spe-
cifically bind members of the hormone receptor super-
family. These factors repress late gene expression when
template copy number is low (Wiley et al., 1993; Zuo and
Mertz, 1995; Zuo, 1995; Zuo et al., 1997).
We have speculated that temporal regulation of other
DNA tumor viruses might also occur in part by transcrip-
tional repression of their late promoters. In the experi-
ments presented here, we tested this hypothesis with
BKV. We show that sequences surrounding the major
transcription initiation site of the late promoter of BKV
strain WW can sequence-specifically bind members of
the NF1 family of transcription factors. As with SV40, the
binding of these cellular factors results in repression of
0042-6822/01 $35.00
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90 KRAUS, SHADLEY, AND MERTZtranscription from BKV’s major late promoter when tem-
plate copy number is low; repression is relieved when
template copy number is high. We also show that the
specific NF1 family members NF1-A4, NF1-C2, and
NF1-X2 can repress transcription from the BKV late pro-
moter in a DNA binding-dependent manner. Thus, se-
quence-specific binding of cellular factors is likely re-
sponsible in part for the replication-dependent compo-
nent of the early-to-late switch in BKV gene expression.
RESULTS
Identification of BKV(WW)’s major late promoter
Previously, Cassill and Subramani (1988) mapped the
59 ends of the late mRNAs synthesized from the Gardner
strain of BKV. They identified a cluster of transcription
start sites within the c element (see Gar strain, Fig. 1B).
Together, these start sites account for approximately 70%
FIG. 1. Map of BK virus ori-promoter regions. (A) Schematic diagra
comprises an origin of replication (ori), an AT-rich region (AT), an enhan
1991). (B and C) Schematic diagram of the promoter-regulatory regi
continuous lines indicate the presence of the same sequences as the a
lines indicate tandemly duplicated sequences. The locations of the NF1
of Markowitz and colleagues (Markowitz and Dynan, 1988; Markowitz e
site was reported by Cassill and colleagues (Cassill et al., 1989), while
rightward arrows indicate the early and late RNA start sites, respectivof the late viral mRNAs accumulated in CV-1 cells. Theyalso identified several other start sites for late RNA
synthesis in other segments of the enhancer region.
We chose to investigate the regulation of late gene
expression of the archetype BKV strain WW (see WW
strain, Fig. 1A), a strain isolated and cloned directly from
human urine without passage in tissue culture. Since
significant quantities of this BK virus strain appear in
human urine under certain physiological conditions
(Chauhan et al., 1984), a productive viral life cycle must
occur in its natural human host. Thus, BKV(WW) might be
of greater biological relevance than strains preselected
to grow well under artificial laboratory conditions. Unfor-
tunately, when BKV(WW) is cultured in established hu-
man cell lines, neither viral early RNA nor viral DNA is
produced in significant quantities (Markowitz and Dynan,
1988; Rubinstein and Harley, 1989). Our attempts to de-
tect BKV late RNA by either S1 nuclease mapping or
primer extension techniques in either human 293 cells or
e WW strain of the BK virus. The promoter region of the WW strain
ion of 68, 39, and 63 bp, and a 63-bp late leader region (Negrini et al.,
the BKV Gardner (Gar) and Dunlop (Dun) strains, respectively. The
al strain. The dashed lines indicate the presence of deletions. Parallel
p1-binding sites within the promoter regions are adopted from the work
90) and Chakraborty and Das (1991). The location of the CREB-binding
-1-binding sites were reported by Moens et al., 1990. The leftward andm of th
cer reg
ons of
rchetyp
- and S
t al., 19
the AP
ely.primate CV-1PD cells transfected with BKV(WW) DNA
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91REGULATION OF BKV BY NF1-LIKE FACTORSproved unsuccessful (data not shown). It is known that
SV40 T-antigen binds to the T antigen-binding sites of
BKV, supporting genomic replication (Ryder et al., 1983).
evertheless, we also failed to detect BKV late RNA in
V40 T antigen-containing COS-M6 cells transfected
ith BKV(WW) DNA (data not shown). Possibly, still miss-
ng was a cellular- or virus-specific function contained
ithin T antigen’s carboxyl-terminal domain needed for
iogenesis of BKV late mRNA.
To overcome these obstacles, we constructed the
lasmid pSVBK2 (Fig. 2A). This plasmid contains a chi-
eric SV40/BKV genome in which (i) the late promoter-
egulatory region of SV40 has been replaced with the
orresponding region of BKV(WW) and (ii) the retained
nitiator element of the SV40-major late promoter (MLP)
as been inactivated. Thus, viral late RNA should primar-
ly be synthesized starting from sequences within the
KV promoter region. This chimeric genome retains
V40’s early promoter, large T antigen-encoding region,
rigin of viral DNA replication, and late RNA processing
ignals and protein-coding regions. Therefore, the viral
NA should replicate to high copy number in African
reen monkey kidney cells, with its late transcripts being
fficiently processed such that their 59 ends could be
eadily mapped.
We transfected primate COS-M6 cells with SVBK2
NA, harvested whole-cell RNA 48 h later, and analyzed
he resulting viral RNAs by primer extension. High levels
f BKV-initiated late RNA were detected, with the 59 ends
apping predominantly to two sites (Fig. 2B, lane 2). The
ajor 59 end accounted for approximately 45% of the
otal viral late RNA and mapped to BKV nt 185 in the BKV
umbering system of Negrini et al. (1991). The second
ite accounted for approximately 30% and mapped to
KV nt 282. This latter site lies downstream of the first
TG codon at BKV nt 266. As a control, we mapped RNA
arvested from COS-M6 cells transfected with XS13, a
utant of SV40 that lacks the enhancer region (Fromm
nd Berg, 1982); we were unable to detect any BKV RNA
Fig. 2B, lane 3). Thus, it is unlikely that the RNA synthe-
ized from SVBK2 DNA arose from transcription within
V40 sequences.
To determine more accurately the major site of tran-
cription initiation from BKV(WW)’s late promoter, these
rimer extension products were also electrophoresed in
high-resolution gel alongside a sequencing ladder of
SVBK2 DNA. The 59 end of the SV40/BKV chimeric
ajor late RNA mapped predominantly to two adjacent
ases within the BKV promoter region, nts 185 and 186
Fig. 2C, lane 2; summarized in Fig. 2D). Although these
9 ends were identified within the context of an SV40
eplicon, we conclude that BKV nts 185 and 186 are
robably the major sites of transcription initiation from
he BKV(WW) late promoter.
We previously reported a method involving weight ma-rices that can be used to predict the relative strengths ofiven sequences as functional Inrs and TBP-binding
ites of promoters transcribed by RNA polymerase II
Kraus et al., 1996). Using our Inr weight matrix, we
alculated that the sequence surrounding the BKV(WW)-
LP start site mapped here, 59-CCAAAG-39, likely func-
ions as a moderately good Inr, with a value approxi-
ately one-fifth that of the optimal initiator sequence
9-NNCA(G/T)T-39. Situated 24–30 bp upstream of this
ranscription initiation site is the sequence 59-AATA-
AC-39 (Fig. 2D). Using our TBP-binding site weight ma-
rix (Kraus et al., 1996), we calculated that this sequence
probably binds TBP quite well, functioning as the 230
region element of an RNA polymerase II promoter with a
value approximately two-thirds that of an optimal TATA
box. We conclude that the late promoter of BKV strain
WW identified here possesses fairly strong basal pro-
moter elements. Thus, it is also likely the major late
promoter of this virus in its natural context and physio-
logical state even though we were unable to reach this
conclusion directly. For the purpose of interpreting the
experiments described below, we will assume this con-
clusion is valid.
NF1 family members bind the BKV(WW)-MLP
It has been shown previously that members of the
steroid/thyroid/retinoid hormone receptor superfamily
bind directly at the initiation site of SV40’s major late
promoter (11 site) and 55 bp downstream of it (155 site),
repressing transcription of the promoter when template
copy number is low (Wiley et al., 1993). These nuclear
receptors include estrogen-related receptor a1 (Wiley et
l., 1993, Johnston et al., 1997), thyroid receptor a1 as a
eterodimer with retinoid X receptor (Zuo, 1995; Zuo et
l., 1997), testis receptor 2 (Zuo, 1995), and the human
omolog of chicken ovalbumin upstream promoter tran-
cription factor 1 (Zuo and Mertz, 1995; Zuo, 1995).
To examine whether the initiator region (Inr) of the
KV(WW)-MLP might also bind one or more of the nu-
lear receptors that recognize the Inr of the SV40-MLP,
e performed competition electrophoretic mobility shift
ssays (EMSAs) with these nuclear receptor proteins
nd radiolabeled double-stranded oligonucleotides cor-
esponding to the SV40-MLP 11 and 155 sites as
robes. A 30-bp double-stranded oligonucleotide corre-
ponding to BKV(WW) nt 217 to nt 113 relative to its
ajor late initiation site failed to compete for binding to
hese receptor proteins (data not shown). This BKV-MLP
NA sequence also failed to compete with these SV40-
LP DNA sequences for binding other proteins present
n a HeLa cell nuclear extract (data not shown). There-
ore, despite the high degree of relatedness between
V40 and BKV in their protein-coding regions, the major
ate promoters of these two viruses are not bound by the
ame nongeneral factors.To look for other factors that might be involved in
r
4
92 KRAUS, SHADLEY, AND MERTZFIG. 2. Identification of BKV’s major late promoter. (A) Schematic representation of the SV40-BKV chimeric plasmid used to map the transcriptional
start site of the BKV-MLP. See Materials and Methods for details of the plasmid construction. Thin line, bacterial cloning vector sequence; thick black
line, BKV sequence extending from the Bsu36I to the KpnI restriction sites; thick gray lines, SV40 sequences; PE and PL, early and late promoters,
espectively, indicating the directions of transcription. (B) Primer extension analysis of the 59 ends of the late viral RNAs accumulated in COS-M6 cells
8 h after transfection with 3 mg/10-mm dish of the indicated DNAs. All RNAs were mapped using a primer corresponding to BKV nts 227–203. Lane
1, sample from mock-transfected cells; lane 2, cells transfected with the chimeric construct SVBK2; lane 3, transfected with SV40 mutant, XS13; lane
4, MspI-cut pBR322 DNA. (C) Localization of the 59 ends of the RNAs synthesized from the BKV late promoter. Whole-cell RNA was harvested from
COS-M6 cells transfected 48 h earlier with SVBK2 DNA and analyzed by primer extension with the same BKV late RNA-specific primer used in B.
Shown here is an autoradiogram of the resulting products electrophoresed in a 7 M urea, 6% polyacrylamide gel (lane 2) alongside dideoxy
sequencing reactions generated with the same primer (lanes 3–6). Lane 1, MspI-cut pBR322 DNA. (D) Schematic representation of the sequences
surrounding BKV’s major late promoter. Arrows indicate the location(s) of the major late transcription initiation site(s) mapped in C. The boxes enclose
the sequences that comprise the putative initiator (Inr) and TBP-binding (TATA box) site elements of this promoter. The nucleotide residues are
numbered relative to the most prominent initiation site as determined from the data in C; 11 corresponds to nt 185 in the numbering system of
BKV(WW) as described by Negrini et al. (1991).
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93REGULATION OF BKV BY NF1-LIKE FACTORSregulating transcription from the BKV-MLP, we performed
direct EMSAs using nuclear extracts from HeLa, CV-1,
and 293 cells as protein sources and a radiolabeled
double-stranded oligonucleotide corresponding to the
30-bp region of the BKV(WW)-MLP described above as
probe (Fig. 3A). Multiple DNA–protein complexes were
observed using HeLa cell nuclear extract (Fig. 3A, lanes
2 and 3), while two relatively fast-migrating species were
observed in the CV-1 nuclear extract (Fig. 3A, lanes 4 and
5). Interestingly, the human kidney cell line 293, derived
from the host tissue and known to enable production of
BK virus, appeared to be devoid of factors that bound the
sequences within this region of the BKV-MLP (Fig. 3A,
lanes 6 and 7).
Markowitz and Dynan (1988) found sites within the
promoter region of the BKV(WW) strain that were pro-
tected from DNaseI cleavage by incubation with a par-
tially purified protein preparation obtained from HeLa
cell nuclei. Five of these sites, including one overlapping
the Inr of the BKV-MLP identified here, closely resemble
the sequence TGGN6GCCAA, the consensus binding site
equence for members of the NF1 family of transcription
actors (Nagata et al., 1982; Gronostajski et al., 1985;
osenfeld and Kelley, 1986) (Fig. 1A).
To test further whether the sequences surrounding the
nr of the BKV-MLP can, indeed, be recognized by NF1-
ike factors, we performed a series of competition elec-
rophoretic mobility shift assays (Fig. 3B; see Fig. 3D for
equences of the oligonucleotides). As expected, the
ouble-stranded oligonucleotide containing a known
F1-binding site competed as well as unlabeled
KV(WT) Inr DNA for binding the factors present in the
eLa cell nuclear extract (Fig. 3B, lanes 7 and 8 vs lanes
and 4). On the other hand, the double-stranded oligo-
ucleotide BKV(mut), which differs from the oligonucleo-
ide BKV(WT) solely in two base pairs known to be
mportant for the binding of NF1 family members, failed
o compete for binding any of these factors (Fig. 3B,
anes 5 and 6 vs lane 2). Therefore, these protein–
KV(WW) DNA complexes likely contain NF1 family
embers.
To confirm the identity of the proteins present in these
omplexes, we performed immunoshift assays using an
ntiserum made against the DNA-binding domain of NF1
hat recognizes an epitope common to all members of
he NF1 family (Fig. 3C). Whereas incubation with preim-
une serum had no effect on the formation of any DNA–
rotein complexes (Fig. 3C, lane 3 vs lane 2), incubation
ith the NF1-specific serum resulted in both the appear-
nce of a slower mobility complex and the marked de-
rease in the formation of the complexes C1, C3, and C4
Fig. 3C, lane 4). Thus, we conclude that members of the
F1 family are the factors present in HeLa cells that bind
equence-specifically to the initiation site of the
KV(WW)-MLP.F1 family members repress transcription from the
KV(WW)-MLP at low template copy number
To examine the effects on transcription in vivo of bind-
ing of NF1 family members to the initiator region of the
BKV(WW)-MLP, we first constructed the SV40-BKV chi-
meric plasmid pSVBK3(WT). This plasmid contains es-
sentially a wild-type SV40 genome except that the se-
quences surrounding the initiator element of the SV40-
MLP have been replaced with ones surrounding the
initiator element of the BKV(WW)-MLP (see Fig. 4A for
sequence). Thus, the viral late promoter is no longer
regulated in part by the hormone receptor-binding site
that surrounds the Inr of the SV40-MLP. Rather, we can
test with this chimeric genome whether the viral late
promoter can be regulated, instead, by the binding of
NF1 family members to the NF1 binding site surrounding
the Inr of the BKV(WW)-MLP. If the binding of NF1 family
members to the BKV(WW)-MLP can regulate late tran-
scription in a manner analogous to hormone receptor
superfamily members binding the SV0-MLP, a mutation
in the NF1 binding site that inactivates binding of the NF1
family members would be predicted to lead to the over-
production of viral late RNA at early times in the lytic
cycle when viral template copy number is low. Con-
versely, by late times in the lytic cycle when template
copy number is high due to viral genome replication, the
effect of this mutation on the accumulation of viral late
RNA would be significantly reduced because titration
would have eliminated in large part promoter occupancy
by the cellular repressors on the wild-type template as
well. Thus, we also constructed plasmid pSVBK3(mut), a
variant of pSVBK3(WT) in which we had mutated the two
base pairs crucial for the binding of NF1 family members
(Fig. 4A).
To check that these chimeric SV40/BKV(WW)-MLPs
function properly in transcription, the viral genomes con-
taining them were excised from their cloning vectors and
transfected in parallel into CV-1PD cells. The 59 ends of
the viral late RNAs accumulated by 48 h posttransfection,
a late time in the lytic cycle of infection of monkey cells,
were determined by primer extension analysis (Fig. 4B).
As expected, predominantly one species of late RNA was
synthesized from the wild-type SV40-MLP (lane 4). In the
SVBK3(WT)-transfected cells, transcripts originated at
high levels from the previously mapped initiation site
(Fig. 2C vs Fig. 4B, lane 2). However, they also originated
at high levels from a new, slightly upstream site posi-
tioned at a more appropriate distance from the previ-
ously identified weak TATA box of the SV40-MLP (Wiley et
al., 1992) and at numerous weakly used sites. Essentially
identical results were obtained with SVBK3(mut), except
for a one-base shift in the major site of initiation likely
caused by the alteration in the specific sequence of the
initiator element (Fig. 4B, lane 3 vs lane 2). Also note-
worthy is the lack of a significant effect of the mutation
94 KRAUS, SHADLEY, AND MERTZFIG. 3. NF1-like factors bind the initiator of the BKV-MLP. (A) Cell type-specific binding to the initiation site region of the BKV-MLP by factors present
in HeLa, CV-1, and 293 cell nuclear extracts. Electrophoretic mobility shift assays (16 ml per reaction) were performed by incubation of the indicated
amounts of HeLa (lanes 2 and 3), CV-1 (lanes 4 and 5), and 293 (lanes 6 and 7) cell nuclear extracts with radiolabeled BKV(WT)-MLP DNA (0.5–1.0
ng) (see D for sequence) and electrophoresis in a native 4% polyacrylamide gel. (B) Sequence-specific competition for binding by oligonucleotides
containing NF1-binding sites. Competition electrophoretic mobility shift assays were performed with HeLa cell nuclear extract, radiolabeled
BKV(WT)-MLP DNA as probe, and the indicated DNAs as unlabeled competitors. The sequences of the DNAs are indicated in D; the NF1-binding site
oligonucleotide corresponds to the one present in the adenovirus origin of DNA replication used in the original identification of NF1 (Nagata et al.,
1982). (C) Effects of anti-CTF/NF1 serum on formation and electrophoretic mobility of BKV(WT)-MLP DNA–protein complexes. EMSAs were performed
with radiolabeled BKV(WT)-MLP DNA as probe, 10 mg HeLa cell nuclear extract as protein source, and 1 ml of the indicated serum. Lane 1, no protein;
lane 2, no serum; lane 3, preincubation of the nuclear extract with a 1:10 dilution of preimmune serum; and lane 4, preincubation with a 1:100 dilution
of an anti-CTF/NF1 serum (kindly provided by Dr. Noko Tanese). (D) Schematic representation of the sequences used as probe and competitor
oligonucleotides in the experiments shown in A–C. The connected shaded boxes indicate the sequences that make up the two halves of the binding
sites for members of the NF1 family of proteins.
95REGULATION OF BKV BY NF1-LIKE FACTORSon the amount of viral late RNA accumulated (Fig. 4B,
lane 3 vs lane 2). This latter finding is consistent with our
hypothesis since the high-viral template copy number
present by 48 h after transfection would be expected to
titrate out putative sequence-specific repressors (Wiley
et al., 1993). Thus, we conclude that these chimeric
promoters synthesize viral late RNA reasonably well.
To examine whether the binding of NF1 family mem-
bers to the Inr of the major late promoter affects the
synthesis of viral late RNA at earlier times in the lytic
cycle of infection, we transfected CV-1PD cells as de-
scribed above, but harvested the cells at earlier times
posttransfection as well. The relative amounts of the
various viral early and late RNA species accumulated in
these cells were determined by quantitative S1 nuclease
FIG. 4. Transcription initiation from the BKV-MLP Inr present within a
chimeric SV40/BKV late promoter. (A) Schematic diagram indicating the
sequences surrounding the initiation sites of the major late promoters
in wild-type SV40, the chimeric SVBK3(WT), and a mutant variant of it,
SVBK3mut. The arrows indicate the major sites of transcription initia-
tion from these promoters as determined from the data presented in B.
The sequences derived from BKV are indicated in italics; the bases
altered in the mutant variant are underlined and lowercase. The nucle-
otide numbers are given relative to the predominant sites of initiation of
the wild-type nonchimeric promoters. (B) Products of primer extension
analysis of the 59 ends of the late viral RNAs accumulated in CV-1PD
cells by 48 h after transfection with 3 mg/10-mm dish of the indicated
viral DNAs. The primer used corresponded to SV40 nt 394–369. Lane 1,
sample from mock-transfected cells processed in parallel; lanes 2–4,
samples from cells transfected with SVBK3, SVBK3mut, and WT SV40
DNA, respectively; and lane 5, MspI-cut pBR322 DNA. Lane 5 was
exposed for a slightly longer period of time than lanes 1–4.mapping (Fig. 5). As predicted, the results obtained werefairly similar to ones observed previously with an SV40
mutant defective in the binding of hormone receptor
superfamily members to the hormone response ele-
ments (HRE) that surround the Inr of the SV40-MLP
(Wiley et al., 1993). Cells transfected with SVBK3(mut)
DNA accumulated four- to eightfold more major late-
initiated RNA by 22 to 26 h posttransfection than did cells
transfected in parallel with SVBK3(WT) DNA (Fig. 5A,
lanes 9 and 10 vs lanes 3 and 4). This difference was
down to twofold by 42 h posttransfection (Fig. 5A, lane 11
vs lane 5). Southern blot analysis showed, as expected,
that the time course of accumulation of viral DNA was
unaffected by the mutation in the NF1-binding site of the
BKV-MLP (Fig. 5B). Therefore, inactivation of an NF1-
binding site surrounding the Inr partially relieves repres-
sion of the BKV major late promoter at early times when
template copy number is low; however, at late times in
the lytic cycle when template copy number is high, the
effect of the mutation becomes smaller, presumably be-
cause of titration of the NF1 family members that repress
transcription of the wild-type promoter.
An alternative hypothesis consistent with these data is
that the mutation in the initiator element creates a better
basal promoter that is more transcriptionally active, with
the loss of binding of NF1-like factors being coincidental
rather than causative. If this were the case, removal of
the NF1 family members by titration in trans would be
predicted to have little, if any, effect on transcription.
Thus, the NF1 binding site mutant would continue to
overproduce late RNA relative to the wild-type promoter
even when NF1 family members were no longer avail-
able to bind to the wild-type promoter.
To test this possibility, we examined the effects of
various competitor oligonucleotides on transcription of
pSVBK3X(WT) vs pSVBK3X(mut) in a cell-free transcrip-
tion system derived from HeLa cells (Fig. 6). These viral
DNA templates are identical to the ones used in the
transfection experiment (see Fig. 4) except for the dele-
tion of the 72-bp repeat enhancer region of SV40. Thus,
transcription of the late promoter is efficiently activated
by SV40’s Sp1 binding sites (Fromm and Berg, 1982;
Wiley et al., 1993; Kraus et al., 1996).
The addition in trans of 25 ng (1.25 pmol) and 50 ng (2.5
pmol) of double-stranded oligonucleotide containing the
initiator region of the BKV-MLP resulted in a three- and
sixfold increase, respectively, in transcription from the
wild-type BKV-MLP (Fig. 6, lanes 3 and 4 vs lane 2),
almost to the level of RNA synthesized from the mutant
template (Fig. 6, lanes 7 and 8 vs lane 4). On the other
hand, the addition in trans of similar quantities of double-
stranded oligonucleotide containing the 2-bp mutation in
the NF1-binding site had little, if any, effect on transcrip-
tion from the wild-type promoter (Fig. 6, lanes 5 and 6 vs
lane 2). As an additional control, the effects of the wild-
type competitor oligonucleotide on transcription from the
NF1-binding site mutant variant, pSVBK3X(mut), were ex-
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96 KRAUS, SHADLEY, AND MERTZFIG. 5. Binding of NF1-like factors to the BKV major late promoter specifically represses BKV late RNA synthesis in vivo. (A) CV-1PD cells were
transfected in parallel with 3 mg/10-mm dish of SVBK3(WT) or SVBK3mut and incubated at 37°C for the times indicated. The relative amounts of the
arly and late viral RNAs present in the cells were analyzed by quantitative S1 nuclease mapping with the double-stranded probe depicted in C.
hown here is the resulting autoradiogram in which the S1 nuclease reaction mixtures contained 25% (lanes 1–3 and 7–9), 12.5% (lanes 4 and 10),
nd 5% (lanes 5 and 11) of the whole-cell RNA present in the dishes of cells. The bands indicated within the bracket labeled BKV major late RNA were
sed to quantify the amounts of BKV late RNA, while the bands indicated by the arrow SV40 E–E were used to quantify the amounts of SV40 early
NA. The numbers at the bottom indicate the amounts of BKV major late RNA relative to SV40 early–early RNA present at the indicated times after
ransfection. These numbers are means 6 SEM of data obtained from three independent experiments similar to the one shown here. The amounts
f BKV major late RNA at 18 h were too low to quantify by this assay. (B) Southern blot analysis of the replicated chimeric viral DNAs present in the
2-, 26-, and 42-h samples analyzed in parallel for viral RNA in A. Each lane contained 2% (lanes 39, 49, 99, 109) or 1% (lanes 59 and 119) of the total
NA present in the sample processed as previously described (Hertz and Mertz, 1986). Lanes 39, 49, 99, and 109 were exposed twice as long as lanes
9 and 119. (C) Structures of the probes used in the S1 nuclease mapping experiment shown in A and the fragments protected by the indicated RNAs.
he numbers indicate the SV40 nucleotide residues in the SV40 numbering system of Buchman et al. (1982).
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97REGULATION OF BKV BY NF1-LIKE FACTORSamined in parallel. As expected, the mutant promoter
was transcribed at high levels regardless of the amount
of competitor present in the reaction (Fig. 6, lanes 7 and
8). Also noteworthy is the absence of effects of these
competitor oligonucleotides on transcription from the
SV40 early promoter present on the same templates (Fig.
6, lanes 19–89). Thus, the effects of these oligonucleo-
tides are sequence specific. We conclude that NF1 fam-
ily members can act as sequence-specific repressors of
the BKV(WW)-MLP.
Finally, we investigated the effects of the wild-type
competitor oligonucleotide on transcription of pBKV(WW)
and pSVBK2 in the cell-free transcription system. Re-
gardless of the conditions tried, we failed to detect late
RNA (data not shown). However, we have successfully
investigated the regulation of the late promoter of the
BKV(WW) strain in a nonchimeric context by using lucif-
erase reporter constructs (see below).
FIG. 6. Addition in trans of a competitor oligonucleotide containing
n NF1-binding site specifically relieves repression of BKV late RNA
ynthesis in a cell-free transcription system. A HeLa cell nuclear
xtract was preincubated at 26°C for 15 min with 25 or 50 ng of a
ouble-stranded oligonucleotide corresponding to the BKV-MLP NF1-
inding site (lanes 3, 4, 7 and 8) or a mutant variant of it (lanes 5 and
) (see Fig. 3D for sequences). Afterward, 200 ng supercoiled plasmid
NA of the indicated wild-type (lanes 2–6) or NF1-binding site mutant
lanes 7 and 8) was added as template and transcription was started by
he addition of NTPs. The viral early and late RNAs synthesized from
hese templates were analyzed by primer extension with primers cor-
esponding to SV40 nt 5136–5160 and 446–422, respectively. The num-
ers at the bottom indicate the ratios of BKV major late to SV40 early
NAs synthesized in each reaction mixture normalized to the late-to-
arly ratio obtained with pSVBK3X(WT) in the absence of competitor
ligonucleotide (lane 2).sNF1-A4, NF1-C2, and NF1-X2 sequence-specifically
bind sequences overlapping the Inr region of the
BKV(WW)-MLP
We next examined specific members of the NF1 family
for binding to the NF1 site overlapping the initiator region
of BKV(WW)-MLP. NF1-A4 and NF1-C2, members of the
NF1-A and NF1-C subfamilies, respectively, share com-
mon amino termini and DNA-binding domains, but differ
in their carboxyl termini. NF1-X2, a member of the NF1-X
subfamily, differs in both the amino and the carboxy
domains from NF1-A4 and NF1-C2 (Kruse and Sippel,
1994). The protein sources for these assays were whole-
cell extracts prepared from 293 cells that had been
transfected 2 days earlier with the expression plasmids
pCHNF1-A, pCHNF1-C, and pCHNF1-X that encode NF1-
A4, NF1-C2, and NF1-X2, respectively. Since 293 cells
lack significant amounts of factors that bind the NF1 site
of the BKV(WW)-MLP (Fig. 3A), the binding factors
present in these extracts should have been largely syn-
thesized from the expression plasmids. As expected,
these extracts generated plasmid-specific protein–DNA
complexes that exhibited different migration rates and
binding patterns (Fig. 7). Binding of NF1-A4 to the Inr
region of the BKV(WW)-MLP generated a single, fast-
migrating protein–DNA complex (Fig. 7, lane 2), while the
binding of NF1-C2 and NF1-X2 generated slower migrat-
ing multicomponent complexes (Fig. 7, lanes 5 and 8,
respectively). These complexes are, presumably, the re-
FIG. 7. NF1-A4, NF1-C2, and NF1-X2 bind the initiator of the BKV-
MLP. EMSAs were performed with radiolabeled BKV(WT)-MLP DNA as
probe, the indicated serum, and the whole-cell extracts obtained from
293 cells (approximately 5 mg of protein) containing overexpressed
F1-A4 (lanes 2–4), NF1-C2 (lanes 5–7), and NF1-X2 (lanes 8–10) as
rotein sources. Lane 1, no protein or antiserum; lanes 2, 5, and 8,
verexpressed NF1-A4, NF1-C2, and NF1-X2 alone, respectively; lanes
, 6, and 9, preincubated with a 1:10 dilution of preimmune serum; and
anes 4, 7, and 10, preincubated with a 1:100 dilution of an anti-CTF/NF1
erum.
98 KRAUS, SHADLEY, AND MERTZsult of NF1 homomeric and/or heteromeric protein–pro-
tein interactions. The NF1-A4 and NF1-C2 protein–DNA
complexes were lost or shifted in mobility following in-
cubation with an antiserum made against the common
DNA-binding domain of NF1 proteins (Fig. 7, lane 4 vs 2
and lane 7 vs 5, respectively), indicating that these spe-
cific NF1 family members bind to the Inr of the BKV(WW)-
MLP. Interestingly, not all of the bands that comprise the
NF1-X2 protein–DNA complex were lost or immuno-
shifted following incubation with the anti-NF1 antiserum
(Fig. 7, lane 10 vs 8). Thus, NF1-X2 can form a specific
protein–DNA complex that apparently blocks the epitope
on NF1-X2 recognized by this antibody.
Competition EMSAs showed that each of the NF1
complexes formed on the Inr of the BKV-MLP bound
sequence-specifically (Fig. 8), including the NF1-X2 an-
tibody-resistant complex (Fig. 8, lanes 16–19). Thus, we
conclude that some members of the NF1 family of pro-
teins bind efficiently and sequence-specifically to the Inr
of the BKV(WW)-MLP. Indeed, it is quite likely that most,
if not all, NF1 family members can bind the Inr of the
BKV(WW)-MLP.
Overexpression of NF1-A4, NF1-C2, and NF1-X2
represses transcription of the BKV(WW)-MLP in 293
cells
Last, we examined the effect of overexpression of
specific NF1 family members on expression of the
BKV(WW)-MLP. A plasmid, pBKLluc (see Fig. 9A), in
which the BKV(WW)-MLP drives expression of a lucif-
erase reporter, was cotransfected into 293 cells along
FIG. 8. Binding of NF-A4, NF1-C2, and NF1-X2 to the Inr of the
radiolabeled BKV(WT)-MLP DNA as probe, oligonucleotides contain
competitors, and the indicated whole-cell extract obtained from 293 ce
protein source.with plasmids expressing each of the specific NF1 familymembers studied above. As controls, luciferase report-
ers driven by the SV40 early promoter (pGL3, Promega
Corp., Madison, WI) and the BZLF1 promoter of EBV
(pWTZpLUC, Kraus et al., 2001), both of which lack any
known NF1 binding sites, were cotransfected in parallel
into 293 cells along with the NF1 expression plasmids.
We found that overexpression of these NF1 family mem-
bers led to repression of transcription from the BKV late
promoter. NF1-C2 and NF1-X2 repressed transcription
from the BKV late promoter approximately 10-fold, while
NF1-A4 repressed approximately threefold (Fig. 9B). As
expected, overexpression of these NF1 family members
had little effect on transcription from the EBV BZLF1 and
SV40 early promoters (Fig. 9B). Thus, squelching of gen-
eral transcription factors or cofactors by the NF1 factors
can be ruled out. Taken together, these findings show
that specific members of the NF1 family can repress
transcription of the BKV(WW) late promoter in a se-
quence-specific manner. They also show that NF1 fac-
tors can repress transcription within the context of the
BKV late promoter, not only in the context of an SV40
chimera.
DISCUSSION
The experiments presented here were designed to
test whether repression of the late genes of BKV contrib-
utes to the temporal regulation of this virus. We chose
the human archetype strain, BKV(WW), since it is the
strain naturally present in the human population. Unfor-
tunately, we were unable to detect viral late mRNA in any
of the cell types we transfected with BKV(WW) DNA (data
LP is sequence specific. Competition EMSAs were performed with
BKV-MLP(WT), or BKV-MLP(mut) sequences shown in Fig. 3D as
proximately 5 mg of protein) containing overexpressed NF1 factors asBKV-M
ing the
lls (apnot shown). These results are in agreement with those of
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99REGULATION OF BKV BY NF1-LIKE FACTORSother groups who showed that the BKV(WW) strain grows
quite poorly in culture, probably because of an inactive
promoter-enhancer region (Rubinstein and Harley, 1989;
Sugimoto et al., 1989; Markowitz et al., 1990). We also
failed to detect synthesis of BKV late RNA in our cell-free
transcription system when BKV(WW) DNA was used as
template (data not shown). Thus, neither an in vivo nor an
in vitro system was available to test directly our hypoth-
esis with the BKV(WW) strain.
Chakraborty and Das (1991) have reported the detec-
tion of BKV late RNA in a cell-free transcription system.
However, their experiment differed from ours in several
respects: (i) they studied the BKV Gardner strain; (ii) they
used linearized DNA as template and an unusually high
FIG. 9. NF1-A4, NF1-C2, and NF1-X2 repress transcription from the
ate promoter of BK virus. (A) Schematics of the luciferase reporter
lasmids assayed here for effects on expression by overexpressed
F1 family members. The BKV nucleotides are in the numbering sys-
em of Negrini et al. (1991). The SV40 nucleotides are in the numbering
system of Buchman et al. (1982). The EBV nucleotides are numbered
elative to the transcriptional initiation site of the BZLF1 promoter
Kraus et al., 2001, and references cited therein). (B) Effects of overex-
ression of NF1-A4, NF1-C2, and NF1-X2 on transcription from the
KV(WW) late, SV40 early, and the EBV BZLF1 promoters. 293 cells
rown in 12-well tissue culture dishes were cotransfected with the
ndicated reporter plasmids (1.0 mg) and NF1 expression plasmids (0.5
mg), incubated for 24 h at 37°C, harvested, and assayed for luciferase
activity. Luciferase activities were normalized to protein levels for each
individual cell extract. They are presented here relative to the activity
obtained from cells cotransfected in parallel with the parental expres-
sion plasmid, pCH, and the same reporter. These numbers are
means 6 SEM of data obtained from three separate experiments, each
performed in triplicate.template-to-protein ratio in their reactions; and (iii) their mmajor late start site mapped approximately 100-bp down-
stream of the in vivo start site.
To overcome the transcriptional inefficiencies of the
BKV(WW) promoter, we constructed the hybrid plasmid
pSVBK2 (Fig. 2A). Late RNA was readily detectable in
COS-M6 cells transfected with this chimeric virus (Fig.
2B), thereby allowing for the first identification of the
major site of transcription initiation from the late pro-
moter of this strain (Fig. 2C; summarized in Fig. 2D). We
found that the start site lies within the core motif,
TGGN6GGCA, of the nuclear factor 1 (NF1) family of
ranscription factors and that members of the NF1 family
f transcription factors bind to this site (Fig. 3). We dem-
nstrated that the binding of trans-acting factors to this
ite sequence-specifically represses transcription in a
oncentration-dependent manner both in vivo (Fig. 5) and
n vitro (Fig. 6). Finally, we identified several specific
embers of the NF1 family, NF1A4, NF1-C2, and NF1-X2,
hat sequence-specifically bind to the BKV-MLP (Figs. 7
nd 8); we showed that these factors can mediate re-
ression of this promoter in a DNA binding-dependent
anner (Fig. 9).
We focused on the regulatory role of the NF1 binding
ite that overlaps the Inr region of the BKV-MLP even
hough the BKV(WW) late promoter contains multiple
F1-binding motifs (Markowitz and Dynan, 1988; Figs. 1
nd 10). We postulated that this binding site might func-
ion as a negative regulatory element of BKV’s late pro-
oter by a mechanism analogous to the way the HRE
verlapping the Inr of the SV40-MLP does (Wiley et al.,
993). Because the BKV(WW) strain grows so poorly in
issue culture, we were unable to test directly our hy-
othesis for the temporal regulation of expression of the
KV genes. Nevertheless, we propose the following
odel (Fig. 10). Following infection of the host, BKV can
stablish a latent state, most likely in an episomal form
Heritage et al., 1981), in which the early genes are
xpressed at low levels and expression of the late genes
s repressed by cellular factors such as NF1 (Fig. 10A).
nder appropriate physiological or exogenous stimuli,
he BKV early promoter is activated for a high level of
xpression, while the late genes remain quiescent (Fig.
0B). When the early gene product, large T antigen, has
ccumulated to sufficient levels, it binds to the viral
rigin of DNA replication (ori) region, both repressing
ranscription of the early promoter and initiating replica-
ion and amplification of the viral genome (Cassill and
ubramani, 1988). Once the viral genome has been am-
lified to sufficiently high levels, repression of the late
romoter is relieved by titration of the repressors,
hereby allowing efficient transcription from the pro-
oter, synthesis of the capsid proteins, and packaging of
iral genomes into virions (Fig. 10C).
In support of this hypothesis, we found that the Inr of
he BKV-MLP sequence-specifically binds NF1 family
embers, repressing transcription, but only when tem-
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100 KRAUS, SHADLEY, AND MERTZplate copy number is low (Figs. 5 and 6). Interestingly, we
failed to observe NF1 DNA-binding activity in nuclear
extract obtained from 293 human kidney cells (Fig. 3A), a
presumed host cell type. Grinnell et al. (1988) reported
similar observations. We have detected weak NF1/DNA
complexes by EMSAs with100 mg of whole-cell extract
obtained from 293 cells (data not shown). Thus, while not
completely devoid of NF1 DNA-binding activity, 293 cells
have, surprisingly, a relatively low abundance of it. Pos-
sibly, NF1 is as abundant in 293 cells as it is in HeLa
cells, but exists in a complexed or posttranslationally
modified state (e.g., phosphorylation) that interferes with
DNA binding under the reaction conditions used here.
Whether the NF1-binding site that overlaps the Inr acts
alone or in combination with other NF1-binding sites
present in the promoter remains to be determined.
Some exogenous agents that activate BKV early tran-
scription are known. Moens et al. (1990) found agents
that stimulate the adenylate cyclase pathway, enhancing
BKV early gene expression several fold. These agents
signal through a c-AMP responsive element, CREB
(Montminy et al., 1986 and references cited therein),
located between nts 75 and 83 (Cassill et al., 1989;
Moens et al., 1990; Fig. 10B). These same authors also
FIG. 10. Model for the mechanism of the replication-dependent comp
ymbols are as shown in Figs. 1 and 3D. The underlined sequence
rogesterone response element (GRE/PRE) (Moens et al., 1994, 1999
egulation of transcription from this promoter.showed that phorbol esters can activate early gene ex-pression, likely through a putative responsive element
located between nts 97 and 104 (Moens et al., 1990).
Regulation by NF1 proteins
NF1 proteins are encoded by a family of four genes,
NF1-A, NF1-B, NF1-C, and NF1-X (Chosdosh et al., 1988;
Gil et al., 1988; Goyal et al., 1990; Kruse and Sippel, 1994).
In addition, these four genes generate isoforms, the
result of multiple alternative RNA splicing events. There
is considerable sequence homology among these pro-
teins within their amino-terminal ends, which contain the
DNA-binding domains. The carboxyl-terminal sequences
are quite diverse. Usually, NF1 factors act as transcrip-
tional activators (Miksicek et al., 1987; Santoro et al.,
1988; Gronostajski et al., 1988; Chakraborty and Das,
1989; Knox et al., 1991; Chakraborty and Das, 1991).
However, there are also multiple examples in which NF1
factors function as transcriptional repressors (e.g., Ad-
ams et al., 1995; Osada et al., 1997; Chaudhry et al.,
1999). We showed here that NF1-A4, NF1-C2, and
NF1-X2 can repress transcription from the BKV late pro-
moter in 293 cells by a sequence-specific mechanism
(Fig. 9).
of the early-to-late switch in BKV gene expression. See text for details.
ate a putative estrogen response element (ERE) and glucocorticoid/
epicted are other, as-yet-unidentified, factors that may contribute toonent
s indic
). Not dGrinnell et al. (1988) found that a HeLa cell-specific
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101REGULATION OF BKV BY NF1-LIKE FACTORSfactor(s) bound to NF1 sites present in the BK virus P2
enhancer, repressing transcriptional activity from this
enhancer. This factor(s), termed BEF-1 for BK virus en-
hancer factor 1, is a 98-kDa protein that is possibly
related to the NF1 family of proteins (Reifel-Miller et al.,
1991). BEF-1 recognizes the NF1 binding site present in
the adenovirus origin of replication (Reifel-Miller et al.,
991), the same sequence called NF1 in Fig. 3D. Since
he NF1 factors present in HeLa cells that bound to the
nr region of BKV(WW)-MLP also bound to the known
F1 site (Fig. 3B), it is quite likely that BEF-1 recognizes
he NF1 site overlapping the Inr of the BKV(WW)-MLP.
ariants of BKV
The various strains of BK virus are distinguishable by
he heterogeneity in their noncoding regions (Fig. 1).
espite complex sequence rearrangements in the en-
ancer region, the early promoter region and early RNA
tart sites are conserved among all of the strains of BKV
solated to date (Deyerle et al., 1987; Deyerele and Sub-
amani, 1988, 1989; Markowitz et al., 1990; see Fig. 1).
owever, considerable heterogeneity exists regarding
heir late transcriptional start sites.
Cassill and Subramani (1988) mapped a cluster of 59
nds of the late RNAs of the BKV(Gar) strain to a location
ithin the c element situated immediately downstream of
he repeat elements (Fig. 1B). The major late transcrip-
ion initiation site mapped to the sequence 59-CAGT-39,
n optimal Inr (Kraus et al., 1996). This Inr region also
ontains an overlapping NF1-binding site. Thus, while
he regulatory regions of these two strains are quite
ifferent in overall structure, the mechanism of repres-
ion of their late promoter may be similar.
egulation of JC virus
Another human polyomavirus, the JC virus (Grinnell et
l., 1983), possesses many features similar to those of
K virus. The archetype, CY (Yogo et al., 1990), has been
isolated from human urine and kidneys, while naturally
occurring variants with rearranged promoter-regulatory
regions have been isolated from human brain tissue
(Rencic et al., 1996). Interestingly, all of the JC virus
strains contain multiple NF1-binding sites within their
promoter-regulatory regions (Amemiya et al., 1992; Raj
and Khalili, 1995). Daniel and Frisque (1993) mapped the
major late RNA start sites of the JCV(Mad1) strain to nts
191–192 and 200–203. Immediately downstream of these
sites (nts 213–219) lies the sequence TGGN6GCC. Se-
uence-specific cellular factors that recognize this re-
ion have been shown to exist in HeLa and brain nuclear
xtract (Khalili et al., 1988). Whether some of these NF1-
inding sites play roles in the early-to-late switch in
xpression of JCV has yet to be determined.
In summary, we have shown here that expression of
he late genes of BKV can be regulated, in part, by theequence-specific binding of at least some members of
he NF1 family of transcription factors. Yet to be deter-
ined is the regulatory role of the other NF1-binding
ites present in this promoter and the molecular mech-
nism of repression of the BKV-MLP by NF1 factors. We
peculate that the binding of repressors to late promot-
rs may be a mechanism frequently employed by DNA
iruses to regulate their genes.
MATERIALS AND METHODS
lasmid DNAs
All plasmids were constructed by standard recombi-
ant DNA techniques (Sambrook et al., 1989). Plasmid
SVS(WT) consists of SV40 wild-type (WT) strain 776
loned into a pBR322-based vector via their EcoRI sites
Buchman et al., 1982; Fromm and Berg, 1982). Plasmid
SV1773(WT) is a derivative of pSVS(WT) containing a
rameshift mutation in the VP1-coding region (Good et al.,
988); it was used in transfection experiments to ensure
hat virion production and, consequently, second cycles
f infection did not occur. Plasmid pSV4503(11/13GGG)
s a derivative of pSV1773(WT) in which SV40’s major late
romoter (SV40-MLP) is inactive because of a substitu-
ion mutation in the initiator element (Inr) (Kraus et al.,
996). Plasmid pBKV(WW), containing BKV wild-type
train WW, was obtained from Dr. R.-B. Markowitz.
The SV40-BKV chimeric plasmid pSVBK2 containing
he Bsu36I–KpnI region of pBKV(WW) cloned into the
phI–KpnI restriction sites of pSV4503 was synthesized
s follows. First, plasmid pBKV(WW9) was generated by
ubcloning of the 5701-bp BglII BKV-containing fragment
f pBKV(WW) into pSP72 (Promega Corp.). Subsequently,
he SV40-BKV chimeric plasmid pSVBK1 was constructed
y substitution of the smaller 1702-bp SphI–KpnI pro-
oter-containing fragment of pBKV(WW9) for the corre-
ponding fragment of pSV4503. Finally, the SV40-BKV
himeric plasmid pSVBK2 was generated by cleavage of
SVBK1 with SphI and Bsu36I, filling in the single-
stranded ends, and relegation (see Fig. 2A).
Plasmid pSV1790 is a derivative of pSV1773 in which
SV40 nucleotide residues (nt) 319–336 in the numbering
system of Buchman et al. (1982) (which include the Inr of
the SV40-MLP) have been replaced by a sequence con-
taining two BspMI sites. Cleavage of pSV1790 with
BspMI yields a vector containing noncomplementary sin-
gle-stranded ends into which synthetic oligonucleotides
can be ligated to substitute for SV40 nt 319–336 inclusive
(Wiley et al., 1993; Kraus et al., 1996). Plasmids pSVBK3
and pSVBK3mut were constructed by ligation into BspMI-
digested pSV1790 of appropriate double-stranded ver-
sions of the synthetic oligonucleotides containing the se-
quence 59-TTCAGTGGAAACTGGCCAAAGGAG-39 (which
includes sequence corresponding to BKV nt 212 through
17 relative to the initiation site of the BKV-MLP) and
59-TTCAGTTGAAACTGGCAAAAGGAG-39 (a mutant vari-
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102 KRAUS, SHADLEY, AND MERTZant of it), respectively (see Fig. 4A). Plasmid pXS13 is a
derivative pSVS lacking the 72-bp enhancer region of
SV40 (i.e., SV40 nt 115–272, inclusive) (Fromm and Berg,
1982). Transcription from the late promoter of this plas-
mid is activated in a cell-free system via the retained
Sp1-binding sites (Wiley et al., 1993; Kraus et al., 1996).
The plasmids pSVBK3X and pSVBK3Xmut, used in the
cell-free transcription experiments (Fig. 6), were gener-
ated by substitution of the promoter-containing KpnI–
EcoRV regions of plasmids pSVBK3 and pSVBK3mut,
respectively, for the corresponding region of pXS13.
Plasmid pGL3 (Promega Corp.) contains the SV40
early promoter driving a luciferase reporter (Fig. 9A).
Plasmid pBKLluc contains a luciferase reporter driven by
the BKV(WW) late promoter (Fig. 9A). It was constructed
by cloning the 276-bp NcoI restriction fragment of pS-
VBK2 (see Fig. 2A) into the NcoI site of plasmid pGL3.
Plasmid pWTZpLUC contains a luciferase reporter driven
by the BZLF1 promoter of Epstein–Barr virus (Kraus et al.,
2001). The NF1 expression plasmids, pCHNF1-A,
pCHNF1-C, and pCHNF1-X, a kind gift from Dr. Richard
M. Gronostajski, express HA-epitope-tagged murine pro-
teins that are homologous to chicken NF1-A4, chicken
NF1-C2, and human NF1-X2, respectively (Kruse and
Sippel, 1994).
All synthetic oligonucleotides were purchased from
Integrated DNA Technologies (Coralville, IA). The se-
quences of all plasmids were confirmed by DNA se-
quence analysis.
Electrophoretic mobility shift assays (EMSAs)
EMSAs were performed as described previously
(Cooney et al., 1992; Zuo, 1995; Zuo et al., 1997) with
nuclear extracts prepared from HeLa cells (Wiley et al.,
1993) and CV-1 cells (Zuo, 1995). Nuclear extracts of 293
cells were obtained as described for CV-1 cells. Whole-
cell extracts containing overexpressed NF1 proteins
were used to assess the binding affinity of specific NF1
proteins for NF1 binding sites present in the BKV late
promoter (Figs. 7 and 8). These latter extracts were
prepared from five 100-mm dishes of 293 cells, grown in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% FBS that had been transfected with 6
mg/dish of the desired NF1 expression plasmid by the
Mirus TansIT-LT1 technique (Pan Vera Corp., Madison,
WI) (see below). Forty-eight hours posttransfection, the
cells were washed with cold PBS, scraped into 2 ml of
cold PBS, pelleted, resuspended in 100 ml of lysis buffer
[50 mM Tris–HCl (pH 7.5), 0.5 M NaCl, 1 mM EDTA, 10%
glycerol, 1 mM DTT, the protease inhibitors 10 mg/ml
leupeptin, 10 mg/ml aprotinin, 2.5 mg/ml pepstatin, and
0.2 mM phenylmethylsulfonyl fluoride (PMSF)] and sub-
jected to three freeze–thaw cycles. Cellular debris was
removed by centrifugation using a desktop centrifuge.
The supernatant was stored at 270°C. MCompetition EMSAs were performed by incubation of
the reaction mixture with the unlabeled competitor oligo-
nucleotide prior to the addition of the radiolabeled probe
DNA. Immunoshift assays were performed by preincuba-
tion of the nuclear extract with the indicated sera (gen-
erously provided by N. Tanese; Nehls et al., 1991) prior to
addition of the probe DNA. All synthetic oligonucleotides
serving as probes were gel purified before use.
Cell-free transcription assays
Cell-free transcription assays were performed as pre-
viously described (Wiley et al., 1992, 1993). Reaction
mixtures (50 ml) contained 200–250 mg protein from a
eLa cell nuclear extract and the indicated amounts of
upercoiled plasmid DNA. The quantities and the 59
nds of the resulting RNAs were determined by primer
xtension analysis as described previously (Good et al.,
988) with 59 end-labeled synthetic oligonucleotides cor-
esponding to SV40 nucleotides 446–422 and 5178–5201
erving as primers for the detection of the late and early
NAs, respectively. The effects of competitor oligonucle-
tides on transcription were determined by incubation of
uclear extract with the competitor oligonucleotide for 15
in at 25–30°C prior to the addition of the template DNA
nd NTPs. The relative amounts of the various RNAs
ere quantified by analysis with a PhosphorImager (Mo-
ecular Dynamics).
ransient transfection assays
The African green monkey kidney cell lines CV-1PD
nd COS-M6 were grown in 100-mm dishes in DMEM
upplemented with 5 and 10% fetal bovine serum, re-
pectively. All transient transfections were performed by
he DEAE–dextran method followed by chloroquine treat-
ent as described previously (Good et al., 1988).
To map the location of the BKV-MLP (Fig. 2), the viral
equences of pSVBK2 were excised from the vector
equences, ligated to form monomer circles, and trans-
ected into COS-M6 cells. Whole-cell RNA was harvested
8 h after transfection. The 59 ends of the pSVBK2 late
NAs synthesized from the chimeric promoter were
apped by primer extension analysis as described pre-
iously (Wiley et al., 1992, 1993; Kraus et al., 1996) with
he synthetic oligonucleotide 59-CCGTCTAACACTGTCT-
CACCTCT-39, corresponding to BKV nt 227–203 (relative
o BKV’s major late initiation site), serving as primer.
In the time-course experiment (Fig. 5), the viral se-
uences of plasmids pSVBK3 and pSVBK3mut were ex-
ised from the vector sequences and ligated to form
onomer circles prior to transfection. Whole-cell RNA
as harvested at the various times indicated. The rela-
ive amounts of viral late RNA accumulated in the trans-
ected CV-1PD cells were determined by quantitative S1
uclease mapping as previously described (Hertz and
ertz, 1988). The S1 nuclease mapping probe was pre-
o
t
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103REGULATION OF BKV BY NF1-LIKE FACTORSpared by PCR with synthetic oligonucleotides corre-
sponding to SV40 nt 4924–4949 and 446–422 serving as
primers and plasmid pSVBK3(WT) serving as template
(Fig. 5C). Southern blots were performed as described
previously (Hertz and Mertz, 1986).
To assess the role specific NF1 factors play in regu-
lating transcription of the BKV promoter (Fig. 9), 0.5 mg of
the indicated NF1 expression plasmids were cotrans-
fected along with 1.0 mg of the desired luciferase reporter
plasmid into 293 cells in 12-well tissue culture dishes,
grown as described above, with the aid of the Mirus
TransIT LT1 transfection reagent (Pan Vera). Briefly, 4 ml
f TransIT LT1 reagent was incubated at room tempera-
ure for 10 min with 100 ml of serum-free DMEM. Next, 1.5
mg of total DNA was added to this mixture and incubated
for an additional 10 min. The TransIT LT1/DNA complex
mixture was added dropwise to cells growing in 1 ml of
fresh growth media. Incubation was continued and cells
harvested at 24 h posttransfection.
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